KRAS and cancer: To investigate the oncogenic relevance of REGγ in KRAS-mutant cancers, we obtained isogenic human colon and lung cancer cells (HCT8, H661, HPNE, and H522) through the introduction of the constitutively active KRASG13D mutation.